Anti-inflammatory properties of doxycycline and minocycline in experimental models: an in vivo and in vitro comparative study

Inflammopharmacology. 2011 Apr;19(2):99-110. doi: 10.1007/s10787-011-0077-5. Epub 2011 Feb 25.

Abstract

Aims and methods: Minocycline (Mino) and doxycycline (Dox) are second generation tetracyclines known to present several other effects, which are independent from their antimicrobial activities. We studied in a comparative way the anti-inflammatory effects of Mino and Dox, on acute models of peripheral inflammation in rodents (formalin test and peritonitis in mice, and carrageenan-induced paw oedema in rats). Immunohistochemical assays for TNF-alpha and iNOS in rat paws of carrageenan-induced oedema were also carried out as well as in vitro assays for myeloperoxidase (MPO) and lactate dehydrogenase (LDH). Furthermore, antioxidant activities were evaluated by the DPPH assay.

Results: In the formalin test although Mino and Dox (1, 5, 10 and 25 mg/kg, i.p.) inhibited the first phase, they acted predominantly on the second phase of the test, where inhibition of the licking time close to 80% were observed. Mino and Dox were very efficacious in reducing the carrageenan-induced paw oedema in rats (10, 25 and 50 mg/kg, i.p.) and carrageenan-induced leucocyte migration (1 and 5 mg/kg, i.p.) to mice peritoneal cavities. Besides, they also significantly inhibited MPO and LDH releases at doses ranging from 0.001 to 1 μg/ml. Thus, in general, the anti-inflammatory activity of Dox was higher as compared to that of Mino, although the radical scavenging activity of Mino was of a magnitude 10 times higher.

Conclusions: Our data indicate that anti-inflammatory and antioxidant effects, involve the inhibition of iNOS and TNF-alpha, among other properties, and these encourage clinical studies of these compounds for new therapeutic applications, especially those were inflammation plays a role.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / chemistry
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Antioxidants / chemistry
  • Biphenyl Compounds / chemistry
  • Carrageenan / pharmacology
  • Cell Movement / drug effects
  • Doxycycline / chemistry
  • Doxycycline / pharmacology
  • Doxycycline / therapeutic use*
  • Edema / chemically induced
  • Edema / metabolism
  • Edema / pathology
  • Edema / prevention & control
  • Formaldehyde / pharmacology
  • Inflammation / chemically induced
  • Inflammation / metabolism
  • Inflammation / pathology
  • Inflammation / prevention & control*
  • L-Lactate Dehydrogenase / blood
  • Male
  • Mice
  • Mice, Inbred Strains
  • Minocycline / chemistry
  • Minocycline / pharmacology
  • Minocycline / therapeutic use*
  • Neutrophils / drug effects
  • Neutrophils / metabolism
  • Neutrophils / pathology
  • Nitric Oxide Synthase Type II / metabolism
  • Oxidation-Reduction
  • Pain / chemically induced
  • Pain / prevention & control
  • Pain Measurement
  • Peritonitis / chemically induced
  • Peritonitis / pathology
  • Peritonitis / prevention & control
  • Peroxidase / metabolism
  • Picrates / chemistry
  • Rats
  • Rats, Wistar
  • Tumor Necrosis Factor-alpha / metabolism
  • alpha-Tocopherol / chemistry

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antioxidants
  • Biphenyl Compounds
  • Picrates
  • Tumor Necrosis Factor-alpha
  • Formaldehyde
  • Carrageenan
  • 1,1-diphenyl-2-picrylhydrazyl
  • L-Lactate Dehydrogenase
  • Peroxidase
  • Nitric Oxide Synthase Type II
  • Nos2 protein, rat
  • Minocycline
  • alpha-Tocopherol
  • Doxycycline